Back
to BiopharmaceuticalGlossaries.com
You are here > Biopharmaceutical
Glossary
Homepage/Search > Biopharmaceutical acronyms Biopharmaceutical
Acronyms
Drug
discovery & development Site Map
Regulatory Affairs Informatics
Site map Technologies Site map Biology
& Chemistry Site map
Finding guide to terms in these glossaries Site
Map This is a work in progress.
BioPax: Biological Pathways Exchange. A collaborative effort to
create a data exchange format for biological pathway data. http://www.biopax.org/
BISTI:
Biomedical Information Science & Technology Initiative
http://www.bisti.nih.gov/bistic2.cfm CBER:
Center for Biologics Evaluation and Research FDA
CDER: Center
for Drug Evaluation and Research, FDA
CDRH:
Center for Devices and Radiological Health, FDA
CFR:
Code of Federal Regulations. Title 21 covers Food and Drugs
CFSAN:
Center for Food Safety and Applied Nutrition
cGMP:
current Good Manufacturing Practice
CLIA: Clinical Laboratory
Improvement Amendments
CRA:
Clinical Research Associate
CRC
Clinical Research Coordinator
EBI:
European Bioinformatics Institute, Hinxton, Cambridge, UK. An EMBL
outstation. http://www.ebi.ac.uk/
eCTD:
Electronic Common Technical Document http://www.fda.gov/cder/regulatory/ersr/ectd.htm
EMA:
European Medicines Agency was EMEA: European Medicines Evaluation Agency
FDA Food
and Drug Administration
FDAMA:
Food
and Drug Modernization Act of 1997
GCP:
Good Clinical Practice
GLP:
Good Laboratory Practice
GMP: Good
Manufacturing Practice
GSK:
GlaxoSmithKline
http://www.gsk.com/
HCV: Hepatitis
C
HIPAA: Health Insurance
Portability and Accounting Act, Health & Human
Services, US
ICH:
International Conference on Harmonisation of Technical Requirements for
Registration of Pharmaceuticals for Human Use
IDE:
Investigational Device Exemption IRB:
Institutional Review Board
IVDMIA:
in Vitro Diagnostic Multivariate Index Assays
J&J,
jnj:
Johnson & Johnson http://www.jnj.com/home.htm
Many companies come under the Johnson & Johnson name. http://www.jnj.com/our_company/family/index.htm
KOLs:
Key Opinion Leaders
MDUFA:
Medical Device User Fee and Modernization Act
MedDRA:
Medical Dictionary for Regulatory Activities MIAME:
Minimum Information About a Microarray Experiment
http://www.mged.org/Workgroups/MIAME/miame.html
NCE:
New Chemical Entity
NCTR:
National Center for Toxicological Research, FDA
NDA:
New Drug Application
NME:
New Molecular Entity
OTC:
Over the Counter drugs
OWG:
Ontology Working Group
http://mged.sourceforge.net/ontologies/index.php PANDRH: Pan
American Network on Drug Regulatory Harmonization
PMA:
PreMarket Approval
PSUR:
Periodic Safety Update Report
REMS: Risk
Evaluation and Mitigation Strategy
Bibliography
Evolving Terminology for Emerging Technologies
Comments? Questions?
Revisions? Mary Chitty mchitty@healthtech.com
Last revised March 23, 2012
View a Printer-Friendly Version of this Web Page!
<%end if%>
BMS: Bristol Myers Squibb
CRI:
Clinical Research Investigator
EFPIA: European Federation
of Pharmaceutical Industries and Associations
IND: Investigational New Drug Application
MHRA: Medicines and Healthcare products Regulatory Agency, UK
PDUFA:
Prescription Drug User Fee Act 1992
SADC: South African Development Community,
and one of the Regional Harmonisation Initiatives (RHIs)
WHO: World Health
Organization, one of the ICH Observers
WSMI: World Self-Medication Industry, and one of the ICH Interested
Parties
FDA Acronyms & Abbreviations, 2010 http://www.fda.gov/aboutfda/fdaacronymsabbreviations/default.htm
Glossary, Association of British Healthcare Industries
Ltd. ,
2007 http://www.abhi.org.uk/glossary/default.aspx
ICH International Conference on Harmonisation of Technical Requirements for
Registration of Pharmaceuticals for Human Use Glossary http://www.ich.org/glossary.html
IUPAC, Abbreviations and acronyms used in the Toxicology Literature, IUPAC
Glossary of Toxicology, 2007 http://sis.nlm.nih.gov/enviro/iupacglossary/annex1.html
IUPAC, Abbreviations and acronyms of names of International Bodies http://sis.nlm.nih.gov/enviro/iupacglossary/annex2.html